[go: up one dir, main page]
Skip to main content
SpringerLink
Log in

Vitamin D as a Cytokine and Hematopoetic Factor

  • Published:
Reviews in Endocrine and Metabolic Disorders Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tsoukas CD, Provvedini DM, Manolagas SC. 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. Science 1984:1438-1441.

  2. Abe E, Miyaura C, Sakagamih H, Takeda M, Kouno K, Yamazaki T, Yoshikias S, Suda T. Differentiation of mouse myeloid leukemia cells induced by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 1981;78:4990-4999.

    Google Scholar 

  3. Adams JS, Sharma OP, Gacad MA, Singer FR. Metabolism of 25-hydroxyvitamin D3 by cultured alveolar macrophages in sarcoidosis. J Clin Invest 1983;72:1856-1860.

    Google Scholar 

  4. Adams JS, Singer FR, Gacad MA, Sharma OP, Hayes MJ, Vouros P, Holick MF. Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab 1985;60:960-966.

    Google Scholar 

  5. Fu GK, Lin D, Zhang MYH, Bikle DD, Shackleton CH, Miller WL, Portale AA. Cloning of human 25-hydroxyvitamin D-1alphahydroxylase and mutations causing vitamin D-dependent rickets type I. Mol Endocrinol 1997;11:1961-1970.

    Google Scholar 

  6. Fu GK, Portale AA, Miller WL. Complete structure of the human gene for the vitamin D 1alpha-hydroxylase, P450c1alpha. DNACell Biol 1997;12:1499-1507.

    Google Scholar 

  7. Kitanaka S, Murayama A, Sakaki T, Inouye K, Seino Y, Fukumoto S, Shima M, Yukizane S, Takayanagi M, Niimi H, Takeyama K, Kato S. No enzyme activity of 25-hydroxyvitamin D3 1alphahydroxylase gene product in pseudovitamin D deficiency rickets, including that with mild clinical manifestations. J Clin Endocrinol Metab 1999;84:4111-4117.

    Google Scholar 

  8. Smith SJ, Rucka AK, Berry JL, Davies M, Mylchreest S, Paterson CR, Heath DA, Tassabehji M, Read AP, Mee AP, Mawer EB. Novel mutations in the 1-α-hydroxylase (P450c1) gene in three families with pseudovitamin D-deficiency rickets resulting in loss of functional enzyme activity in blood-derived macrophages. J Bone Miner Res 1999;14:730-739.

    Google Scholar 

  9. Barbour GL, Coburn JW, Slatopolsky E, Norman AW, Horst RL. Hypercalcemia in an anephric patient with sarcoidosis. N Engl J Med 1981;305:440-443.

    Google Scholar 

  10. Adams JS, Gacad MA. Characterization of 1alpha-hydroxylation of vitamin D3 sterols by cultured macrophages from patients with sarcoidosis. J Exp Med 1985;161:755-765.

    Google Scholar 

  11. Bell NH. Renal and nonrenal 25-hydroxyvitamin D-1alphahydroxylases and their clinical significance. J Bone Miner Res 1998;13:350-353.

    Google Scholar 

  12. Okuda KI, Usui E, Ohyama Y. Recent progress in enzymology and molecular biology of enzymes involved in vitamin D metabolism. J Lipid Res 1995;36:1641-1652.

    Google Scholar 

  13. Adams JS, Ren S-Y, Arbelle JE, Clemens TL, Shany S. A role for nitric oxide in the regulated expression of the 25-hydroxyvitamin D-1-hydroxylation reaction in the chick myelomonocytic cell line HD-11. Endocrinology 1994;134:499-502.

    Google Scholar 

  14. Adams JS, Ren S-Y. Autoregulation of 1,25-dihydroxyvitamin D synthesis in macrophage mitochondria by nitric oxide. Endocrinology 1996;137:4514-4517.

    Google Scholar 

  15. Adams JS, Modlin RL, Diz MM, Barnes PF. Potentiation of the macrophage 25-hydroxylation reaction by human tuberculous pleural effusion fluid. J Clin Endocrinol Metab 1989;69:457-460.

    Google Scholar 

  16. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1,25-Dihydrovitamin D3 receptors in human leukocytes. Science 1983;221:1181-1182.

    Google Scholar 

  17. Bhalla AK, Amento EP, Clemens TL, Holick MF, Krane SM. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells. J Clin Endocrinol Metab 1983;57:1308-1310.

    Google Scholar 

  18. Rigby W. The immunobiology of vitamin D. Immunol Today 1988;9:54-58.

    Google Scholar 

  19. Hewison M. Vitamin D and the immune system. J Endocrinol 1992;132:173-175.

    Google Scholar 

  20. Fagan DL, Prehn JL, Jordan SC, Adams JS. The human myelomonocytic cell line U937 as a model for studying alterations in monokine gene expression by 1,25-dihydroxyvitamin D. Mol Endocrinol 1991;5:179-186.

    Google Scholar 

  21. Bar-Shavit Z, Teitelbaum SL, Reitsma P, Hall A, Pegg LE, Trial J, Kahn AJ. Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 1983;80:5907-5910.

    Google Scholar 

  22. Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC. 1,25-Dihydroxyvitamin D suppresses human T helper-inducer lymphocyte activity in vitro. J Immunol 1985;134:219-224.

    Google Scholar 

  23. Bhalla AK, Amento EP, Krane SM. Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/ macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol 1986;98:311-322.

    Google Scholar 

  24. Ucla C, Roux-Lombard P, Dayer J-M, Mach B. IFN-gamma drastically modifies the regulation of IL-1 genes by endotoxin in U937 cells. J Clin Invest 1990;85:185-191.

    Google Scholar 

  25. Morel PA, Manolagas SC, Provvedini DM, Wegmann DR, Chiller JM. Interferon-gamma-induced IA expression in WEHI-3 cells is enhanced by the presence of 1,25-dihydroxyvitamin D3. J Immunol 1986;136:2181-2186.

    Google Scholar 

  26. Rook GAW, Steele J, Fraher L, Barker S, Karmali R, O'Riordan J. Vitamin D3, gamma-interferon, and control of proliferation of myobacterium tuberculosis by human monocytes. Immunology 1986;57:159-163.

    Google Scholar 

  27. Jordan SC, Lemire JM, Kieffler PK, Sakai R, Adams JS. Immunoregulatory and prodifferentiating effect of 1,25-dihydroxyvitamin D. In: Nutrient Modulation of the Immune Response. New York: Marcel Dekker, 1992;3-29.

    Google Scholar 

  28. Manolagas SC, Provvedini DM, Murray EJ, Tsoukas CD, Deftos LJ. The antiproliferative effect of calcitriol on human peripheral blood mononuclear cells. J Clin Endocrinol Metab 1986;63:394-400.

    Google Scholar 

  29. Rigby WF, Noelle RJ, Krause K, Fanger MW. The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation. J Immunol 1985;135:2279-2286.

    Google Scholar 

  30. Nun JD, Katz DR, Barker S, Fraher LJ, Hewison M, Hendy GN, O'Riordan JL. Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3. Immunology 1986;59:479-484.

    Google Scholar 

  31. Lemire JM, Adams JS, Sakai R, Jordan SC. 1,25-Dihydroxyvitamin D suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 1984;74:857-861.

    Google Scholar 

  32. Rigby WFC, Denome S, Fanger MW. Regulation of lymphokine production and human T lymphocyte activation by 1,25-(OH)2D3. J Clin Invest 1987;79:1659-1664.

    Google Scholar 

  33. Lemire JM, Adams JS. 1,25-Dihydroxyvitamin D inhibits delayedtype hypersensitivity mediated by T-cell clones inducing experimental autoimmune encephalomyelitis. J Bone Miner Res 1992;7:171-178.

    Google Scholar 

  34. Lemire JM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr 1995;125:1704S-1708S.

    Google Scholar 

  35. Lemire JM. Immunomodulatory actions of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 1995;53:599-602.

    Google Scholar 

  36. Barnes PF, Modlin RL, Bikle DD, Adams JS. Transpleural gradient of 1,25-dihydroxyvitamin D in tuberculous pleuritis. J Clin Invest 1989;83:1527-1532.

    Google Scholar 

  37. Rook GAW, Taverne J, Leveton C, Steele J. The role of gammainterferon, vitamin D3 metabolites and tumor necrosis factor in the pathogenesis of tuberculosis. Immunology 1987;62:229-234.

    Google Scholar 

  38. Rook GAW. The role of vitamin D in tuberculosis. Am Rev Respir Dis 1988;138:768-770.

    Google Scholar 

  39. Mawer EB, Hayes ME, Still PE, Davies M, Lumb GA, Palit J, Holt PJL. Evidence for nonrenal synthesis of 1,25-dihydroxyvitamin D in patients with inflammatory arthritis. J Bone Miner Res 1988;6:733-739.

    Google Scholar 

  40. Hayes ME, Bayley D, Still P, Palit J, Denton J, Freemont AJ, Cooper RG, Mawer EB. Differential metabolism of 25-hydroxyvitamin D3 by cultured synovial fluid macrophages and fibroblastlike cells from patients with arthritis. Ann Rheum Dis 1992;51:220-226.

    Google Scholar 

  41. Hayes ME, O'Donoghue DJ, Ballardie FW, Mawer EB. Peritonitis induces the synthesis of 1alpha, 25-dihydroxyvitamin D3 in macrophages from CAPD patients. FEBS 1987;220:307-310.

    Google Scholar 

  42. Shany S, Rapoport J, Zuili I, Gavriel A, Lavi N, Chaimovitz C. Metabolism of 25-OH-vitamin D3 by peritoneal macrophages from CAPD patients. Kid Int 1991;39:1005-1011.

    Google Scholar 

  43. Bunce CM, Brown G, Hewison M. Vitamin D and hematopoiesis. Trends in Endocrinology and Metabolism 1997;8:245-251.

    Google Scholar 

  44. Bouillon R, Okamura WH, Norman AW. Structure-functionrelationships in the vitamin D endocrine system. Endocr Rev 1995;16:200-257.

    Google Scholar 

  45. Bouillon R, Garmyn M, Verstuyf A, Segaert S, Casteels K, Mathieu C. Paracrine role for calcitriol in the immune-system and skin creates new therapeutic possibilities for vitamin D analogs. European J Endocrinol 1995;133:7-16.

    Google Scholar 

  46. Munker R, Norman AW, Koeffler HP. Vitamin D compounds: effect on clonal proliferation and differentiation of human myeloid cells. J Clin Invest 1986;78:424-430.

    Google Scholar 

  47. Grande A, Manfredini R, Pizzanelli M, Tagliafico E, Balestri R, Trevisan F, Barbieri D, Franceschi C, Battini R, Ferrari S, Ferrari S. Presence of a functional vitamin D receptor does not correlate with vitamin D3 phenotypic effects in myeloid differentiation. Cell Death Differentiation 1997;4:497-505.

    Google Scholar 

  48. Abe E, Miyaura C, Sakagami K, Takeda M, Konno K, Yamazaki T, Yoshiki S, Suda T. Differentiation of mouse myeloid leukemia cells induced by 1α,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 1981;78:4990-4994.

    Google Scholar 

  49. Koeffler HP, Amatruda T, Ikekawa N, Kobayashi Y, Deluca HF. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its-fluorinated analogs. Cancer Res 1984;44:5624-5628.

    Google Scholar 

  50. Mangelsdorf DJ, Koeffler HP, Donaldson CA, Pike JW, Haussler MR. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptormediated maturation to macrophage-like cells. J Cell Biol 1984;98:391-398.

    Google Scholar 

  51. Amento EP, Bhalla AK, Kurnick JT, Kradin RL, Clemens TL, Holick SA, Holick MF, Krane SM. 1-alpha,25-Dihydroxyvitamin D3</del> induces maturation of the human monocyte cell line U937, and, in association with a factor from human T-lymphocytes, augments production of the monokine, mononuclear cell factor. J Clin Invest 1984;73:731-739.

    Google Scholar 

  52. McCarthy DM, San Miguel JF, Freake HC. 1,25-dihydroxy vitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal bone marrow cells. Leukocyte Res 1983;7:51-54.

    Google Scholar 

  53. Kizaki M, Norman AW, Bishop JE, Lin CW, Karmakar A, Koeffler HP. 1,25-Dihydroxyvitamin D3 receptor RNA expression in hematopoietic cells. Blood 1991;77:1238-1247.

    Google Scholar 

  54. Hewison M, Barker S, Brennan A, Nathan J, Katz DR, O'Riordan JLH. Autocrine regulation of 1,25-dihydroxycholecalciferol metabolism in myelomonocytic cells. Immunology 1989;68:247-252.

    Google Scholar 

  55. Duits AJ, Dimjati W, van de Winkel JGJ, Capel PJA. Synergism of interleukin 6 and 1α,25-dihydroxyvitamin D3 in induction of myeloid differentiation of human leukemic cell lines. J Leukoc Biol 1992;51:237-243.

    Google Scholar 

  56. James SY, Williams MA, Kelsey SM, Newland AC, Colston KW. Interaction of vitamin D derivatives and granulocyte-macrophage colony-stimulating factor in leukaemic cell differentiation. Leukemia 1997;11:1017-1025.

    Google Scholar 

  57. Verstuyf A, Mathieu C, Verlinden L, Waer M, Tan BK, Bouillon R. Differentiation induction of human leukemia cells (HL60) by a combination of 1,25-dihydroxyvitamin D3 and retinoic acid (all trans or 9-cis). J Steroid Biochem Molecular Biol 1995;53:431-441.

    Google Scholar 

  58. Rachez C, Lemon BD, Suldan Z, Bromleigh V, Gamble M, Naar AM, ErdjumentBromage H, Tempst P, Freedman LP. Liganddependent transcription activation by nuclear receptors requires the DRIP complex. Nature 1999;398:824-828.

    Google Scholar 

  59. Muller R, Curran T, Muller D, Guilbert L. Induction of c-fos during myelomonocytic differentiation and macrophage proliferation. Nature 1985;314:546-548.

    Google Scholar 

  60. Karmali R, Bhalla A, Farrow SM, Lydyard P, O'Riordan JLH. 1,25-dihydroxycholecalciferol regulates oncogene expression in U937 cells. J Mol Endocrinology 1989;3:43-50.

    Google Scholar 

  61. Rots NY, Iavarone A, Bromleigh V, Freedman LP. Induced differentiation of U937 cells by 1,25-dihydroxyvitamin D3 involves cell cycle arrest in G1 that is preceded by a transient proliferative burst and an increase in cyclin expression. Blood 1999;93:2721-2729.

    Google Scholar 

  62. Lill MC, Fuller JF, Herzig R, Crooks GM, Gasson JC. The role of the homeobox gene, Hox B7, in human myelomonocytic differentiation. Blood 1995;85:692-697.

    Google Scholar 

  63. Rots NY, Liu M, Anderson EC, Freedman LP. A differential screen for ligand-regulated genes: IdentiÆcation of HoxA10 as a target of vitamin D3 induction in myeloid leukemic cells. Mol Cell Biol 1998;18:1911-1918.

    Google Scholar 

  64. Ogata E. The potential use of vitamin D analogs in the treatment of cancer. Calc Tissue Int 1997;60:130-133.

    Google Scholar 

  65. Honma Y, Hozumi M, Abe E, Konno K, Fukushima M, Hata S, Nishii Y, DeLuca HF, Suda T. 1α,25-Dihydroxyvitamin D3 and 1α-hydroxyvitamin D3 prolong survival time of mice innoculated with myeloid leukaemia cells. Cell Biol 1983;80:201-204.

    Google Scholar 

  66. Ambrosio D, Cippitelli M, Cocciolo M, Mazzeo D, Di Lucia P, Lang R, Sinigaglia F, Panina-Bordignon P. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. J Clin Invest 1998;101:252-262.

    Google Scholar 

  67. Lemire JM, Beck L, Faherty D, Gately MK, Spiegelberg HL. 1,25-Dihydroxyvitamin-D3 inhibits the production of IL-12 by human monocytes and B cells. FASEB 1993;8:A745.

    Google Scholar 

  68. Lemire JM, Adams J, Kermani-Arab V, Bakke A, Sakai R, Jordan C. 1,25-Dihydroxyvitamin D3 suppresses human helper/ inductor lymphocyte activity in vitro. J Immunol 1985;34:3032-3035.

    Google Scholar 

  69. Rigby WFC, Demome S, Fanger MW. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. J Clin Invest 1987;79:1659-1664.

    Google Scholar 

  70. Reichel H, Koeffler HP, Tobler A, Norman AW. 1,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci USA 1987;84:3385-3389.

    Google Scholar 

  71. Lemire JM, Adams JS, Sakai R, Jordan SC. 1,25 Dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 1985;74:657-661.

    Google Scholar 

  72. Müller K, Heilmann C, Poulsen L, Barington T, Bendtzen K. The role of monocytes and T cells in T cells and 1,25-dihydroxyvitamin D3 mediated inhibition of B cell function in vitro. Immunopharmacology 1991;21:121-128.

    Google Scholar 

  73. Lemire JM, Ince A, Cox P, Kohl S. 1,25-Dihydroxyvitamin D3 selectively interferes with cellular mechanisms of cytotoxicity. Kidney Intl 1990;37:420.

    Google Scholar 

  74. Merino F, Alvarez-Mon M, De la Hera A, Ales JR, Bonilla F, Durantez A. Regulation of natural killer cytotoxicity by 1,25-dihydroxyvitamin D3. Cell Immunol 1989;118:328-336.

    Google Scholar 

  75. Leung KH. Inhibition of human natural killer cell and lymphokineactivated killer cell cytotoxicity and differentiation by vitamin D3. Scand J Immunol 1989;30:199-208.

    Google Scholar 

  76. Meehan MA, Kerman RH, Lemire JM. 1,25-Dihydroxyvitamin D3 enhances generation of non-specific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR. Cell Immunol 1992;140:400-409.

    Google Scholar 

  77. Tokuda N, Mizuki N. 1,25-Dihydroxyvitamin D3 downregulation of HLA-DR on human peripheral blood monocytes. Immunology 1992;75:349-354.

    Google Scholar 

  78. Xu H, Soruri A, Gieseler R, Peters J. 1,25-Dihydroxyvitamin D3 exerts opposing effects to IL4 on MHC class II antigen expression, accessory activity and phagocytosis on human monocytes. Scand J Immunol 1993;38:535-540.

    Google Scholar 

  79. Lemire JM, Archer DC. 1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 1991;87:1103-1107.

    Google Scholar 

  80. Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis. Proc Natl Acad Sci USA 1996;93:7861-7864.

    Google Scholar 

  81. Lemire JM. The role of vitamin D3 in immunosuppression: Lessons from autoimmunity and transplantation In: Feldman D, Glorieux F, Pike JW, eds, Vitamin D. San Diego: Academic Press, 1997;1167-1181.

    Google Scholar 

  82. Mathieu C, Laureys J, Sobis H, Vandeputte M, Waer M, Bouillon R. 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes 1992;41:1491-1495.

    Google Scholar 

  83. Mathieu C, Waer M, Casteels K, Laureys J, Bouillon R. Prevention of type 1 diabetes by non-hypercalcemic doses of a new structural analog of 1,25(OH)2D3, KH1060. Endocrinology 1995;136:866-872.

    Google Scholar 

  84. Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R. Prevention of type 1 diabetes in NOD mice by 1,25-dihydroxyvitamin D3. Diabetologia 1994;37:552-558.

    Google Scholar 

  85. Casteels K, Waer M, Bouillon R, Depovere J, Valckx D, Laureys J, Mathieu C. 1,25-Dihydroxyvitamin D3 restores sensitivity to cyclophosphamide-induced apoptosis in non-obese diabetic (NOD) mice and protects against diabetes. Clin Exp Immunol 1998;112:181-187.

    Google Scholar 

  86. Casteels KM, Gysemans CA, Waer M, Bouillon R, Laureys JM, Depovere J, Mathieu C. Treatment with 1,25(OH)2D3 restores defect. Diabetes 1998;47:1033-1037.

    Google Scholar 

  87. Casteels K, Mathieu C, Waer M, Valckx D, Overbergh L, Laureys J, Bouillon R. Prevention of type 1 diabetes in NOD mice by late intervention with non-hypercalcemic analogs of 1,25(OH)2D3 in combination with a short induction course of cyclosporin A. Endocrinology 1998;139:95-102.

    Google Scholar 

  88. Lemire JM, Ince A, Takashima M. 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity 1992;12:143-148.

    Google Scholar 

  89. Lemire JM, Archer DC, Khulkarni A, Ince A, Uskokovic MR, Stephkowsky S. The vitamin D3 analog, 1,25-dihydroxy-)16-cholecalciferol prolongs the survival of murine cardiac allografts. Transplantation 1992;54:762-763.

    Google Scholar 

  90. Veyron P, Pamphile R, Binderup L, Touraine JL. Two novel vitamin D analogs, KH 1060 and CB 966, prolong skin allograft survival in mice. Transpl Immunol 1993;1:72-76.

    Google Scholar 

  91. Johnsson C, Tufveson G. MC 1288. A vitamin D analog with immunosuppressive effects on heart and small bowel grafts. Transplant Int 1994;7:392-397.

    Google Scholar 

  92. Perez A, Raab R, Chen TC, Turner A, Holick MF. Safety and efficacy of oral calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis. Brit J Derm 1996;134:1070-1078.

    Google Scholar 

  93. Humbert P, Dupond JL, Agache P, Laurent R, Rochefort A, Drobacheff C, de Wazieres B, Aubin F. Treatment of scleroderma with oral 1,25-Dihydroxyvitamin D3: Evaluation of skin involvement using non-invasive techniques. Acta Derm Venereol 1993;73:449-451.

    Google Scholar 

  94. Santana-Sahagun JE, Lemire J, Albani S, Eichenfield L, Weisman MH. Safety and tolerability of calcitriol therapy as a disease-modifying agent in systemic sclerosis: an open pilot study. American Society of Rheumatology Meeting, Boston, November, 1999.

Download references

Author information

Authors and Affiliations

  1. Division of Medical Sciences, Institute of Clinical Research, The University of Birmingham, Birmingham, B15-2TH, UK

    Martin Hewison

  2. Division of Endocrinology, Diabetes, and Metabolism, Cedars-Sinai Medical Center, UCLA School of Medicine, Burns and Allen Research Institute, Los Angeles, California, 90048

    Mercedes A. Gacad & John S. Adams

  3. Division of Pediatric Nephrology, University of California, San Diego, 9500 Gilman Drive, 0831, La Jolla, CA, 92093-0831

    Jacques Lemire

Authors
  1. Martin Hewison
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mercedes A. Gacad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jacques Lemire
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John S. Adams
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hewison, M., Gacad, M.A., Lemire, J. et al. Vitamin D as a Cytokine and Hematopoetic Factor. Rev Endocr Metab Disord 2, 217–227 (2001). https://doi.org/10.1023/A:1010015013211

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1010015013211

Search

Navigation